Abstract
Hyperammonemia, a life-threatening condition, is a common complication of a wide variety of disorders as well as a primary etiologic agent of hepatic encephalopathy (HE), a decline in brain functions secondary to advanced liver dysfunction and failure. Measurements of ammonia in blood were first described more than a century ago and since then, several new methods have been proposed for the determination of ammonia in biological fluids. The direct enzymatic determination of ammonia in plasma is nowadays the most commonly used ammonia assay in clinical chemistry. Here, we summarize the current recommendations for the quantification of ammonia in biological fluids, in particular in plasma, by listing sample pre-analysis handling requisites and principal potential contaminants.
Ammonia homeostasis is a whole-body dynamic process tightly regulated. Assessing the altered accumulation of ammonia and disrupted metabolism in the different organ/systems tissues is important for increasing our knowledge of the underlying disturbed molecular mechanisms in a series of pathologies. Therefore, the establishment of adequate methodologies for the detection of ammonia in mammalian tissue is of paramount importance. Herein, we provide a detailed description of a method for detecting ammonia in formalin-fixed paraffin-embedded mammalian tissue. This histological-based method takes advantage of the Nessler colorimetric reaction to detect ammonia analyzing this metabolite distribution in specific regions of interest of the mammalian brain, liver, and other organs of interest.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Huizenga JR, Tangerman A, Gips CH (1994) Determination of ammonia in biological fluids. Ann Clin Biochem 31(Pt 6):529–543
Gebhardt R, Matz-Soja M (2014) Liver zonation: novel aspects of its regulation and its impact on homeostasis. World J Gastroenterol 20(26):8491–8504
Jungermann K, Kietzmann T (1996) Zonation of parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr 16:179–203
Wang P et al (2023) Gut microbiome-derived ammonia modulates stress vulnerability in the host. Nat Metab 5:1986–2001
Mathias RS, Kostiner D, Packman S (2001) Hyperammonemia in urea cycle disorders: role of the nephrologist. Am J Kidney Dis 37(5):1069–1080
Haberle J et al (2018) Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories. Orphanet J Rare Dis 13(1):219
Glasgow AM, Cotton RB, Dhiensiri K (1972) Reye’s syndrome. I. Blood ammonia and consideration of the nonhistologic diagnosis. Am J Dis Child 124(6):827–833
Kenzaka T et al (2015) Hyperammonemia in urinary tract infections. PLoS One 10(8):e0136220
Nott L et al (2007) Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy. Leuk Lymphoma 48(9):1702–1711
Segura-Bruna N et al (2006) Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand 114(1):1–7
Kotsiliti E (2022) Hyperammonaemia in liver cirrhosis. Nat Rev Gastroenterol Hepatol 19(10):624
Jalan R, Lee WM (2009) Treatment of hyperammonemia in liver failure: a tale of two enzymes. Gastroenterology 136(7):2048–2051
Jover-Cobos M, Khetan V, Jalan R (2014) Treatment of hyperammonemia in liver failure. Curr Opin Clin Nutr Metab Care 17(1):105–110
Butterworth RF (2000) Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol 32(1 Suppl):171–180
Kaplon J et al (2019) Improved assay protocol for measurement of ammonia on the Roche Cobas 8000 automated platform. Pract Lab Med 13:e00115
Wannasilp N et al (2006) Heparin is an unsuitable anticoagulant for the detection of plasma ammonia. Clin Chim Acta 371(1–2):196–197
Wannasilp N et al (2005) EDTA should be the anticoagulant of choice for the measurement of plasma ammonia: report of a problem sample. Clin Chim Acta 357(1):84–85
Barsotti RJ (2001) Measurement of ammonia in blood. J Pediatr 138(1 Suppl):S11–9;discussion S19–20
Haberle J (2011) Clinical practice: the management of hyperammonemia. Eur J Pediatr 170(1):21–34
Rodriguez-Agudo R et al (2022) Methionine cycle rewiring by targeting miR-873-5p modulates ammonia metabolism to protect the liver from acetaminophen. Antioxidants (Basel) 11(5):897
De Chiara F et al (2018) Urea cycle dysregulation in non-alcoholic fatty liver disease. J Hepatol 69(4):905–915
Gutierrez-de-Juan V et al (2017) A morphological method for ammonia detection in liver. PLoS One 12(3):e0173914
Ballester MP et al (2023) Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis. J Hepatol 79(4):967–976
Mercado-Gomez M et al (2024) The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis. Metabolism 158:155952
Thomsen KL et al (2023) Role of ammonia in NAFLD: an unusual suspect. JHEP Rep 5(7): 100780
Acknowledgments
Teresa C. Delgado is funded by “Ayuda RYC2020-029316-I financiada por MCIN/AEI/10.13039/501100011033 y por El FSE invierte en tu futuro.” This work was supported by the Gilead Sciences Research Scholars Program in Global Liver (to TCD), grant from Ministerio de Ciencia, Innovación y Universidades (MICINN: PID2022-139395OB-100 integrado en el Plan Estatal de Investigación Científica y Técnica e Innovación, con Fondos FEDER). This work was supported by grants from Ministerio de Ciencia, Innovación y Universidades MICINN: PID2020-117116RB-I00 integrado en el Plan Estatal de Investigación Científica y Técnica e Innovación, cofinanciado con Fondos FEDER for (MLM-C); Project funded by CIBEREHD. This work was partially funded by the Basque Department of Health (2023222005) (for JdH). JdH and TCD are members of the European Reference Network for Rare Hereditary Metabolic Disorders (MetabERN) Project ID No. 739543.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2025 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Delgado, T.C., de las Heras, J., Martínez-Chantar, M.L. (2025). Nessler Histological Staining for Ammonia Detection in Formalin-Fixed Paraffin-Embedded (FFPE) Mammalian Tissue. In: Balzano, T. (eds) Experimental and Clinical Methods in Hepatic Encephalopathy Research. Neuromethods, vol 219. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-4354-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-0716-4354-9_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-4353-2
Online ISBN: 978-1-0716-4354-9
eBook Packages: Springer Protocols